SARMs

S4 25 mg Astera Labs

Astera Labs

60,00

In Stock (100 available)

S4 25 mg Astera Labs (25 mg) — This Astera Labs formulation delivers andarine (S-4) is a first-generation SARM producing moderate muscle-building effects with no…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost
Categories: ,

Description

S4 25 mg Astera Labs — This Astera Labs formulation delivers andarine (S-4) is a first-generation SARM producing moderate muscle-building effects with notable fat loss and hardening properties. It creates a lean, dry physique similar to Winstrol but with significantly reduced side effects. Particularly valued during cutting phases. This formulation is dosed at 25 mg per unit.

Key Benefits

  • S-4 SARM — selective androgen receptor activation with partial profile
  • Effective at body-recomposition dosing
  • Distinct visual side-effect (yellow tinge) from ocular-pigment binding
  • Oral once or twice daily
  • Mild HPTA suppression — mini-PCT advisable
  • Each unit dosed at 25 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 25–50 mg/day split twice daily for 6–8 weeks. Split dosing smooths plasma. Above 50 mg/day the visual side-effect (yellow tinge / night-vision impairment) amplifies.

How It Works

Selective androgen receptor modulator with partial agonism profile. Tissue-selective effect on muscle and bone with minimal prostate/skin impact. Downstream anabolic signal milder than full-potency SARMs (ligandrol, RAD-140).

Pharmacokinetics

Plasma half-life approximately 4 hours — twice-daily dosing required. Oral bioavailability reasonable. Reconstituted oil or powder stable at room temperature.

Potential Side Effects

Signature visual disturbance: yellowing tint to vision, especially in low light. Resolves within 1–2 weeks of discontinuation. Mild HPTA suppression. HDL drops slightly.

Cycle & Stacking Guide

6–8 week cycles, 25–50 mg/day. Mini-PCT (Nolva 20 mg × 3 weeks) after 8-week runs. Often stacked with Ostarine or cardarine for cutting protocols.

Manufacturer Notes

Astera Labs produces a broad catalogue from research peptides to AAS oils. Lyophilised peptide vials ship with stability documentation.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “S4 25 mg Astera Labs”

Your email address will not be published. Required fields are marked *